Table 5. Correlation Between P53 and Bcl-2 Expression With Clinico-pathological Data.

	N	P53 Expression				Bcl-2 Expression
		%	p1	Score ± SD	p2	%	p1	Score ± SD	p2
Age (years)			0.611		0.372		0.153		0.230
≤ 55	31	71		3.23 ± 3.48		38.7		0. 84 ± 1.65
>55	26	76.9		4.08 ± 3.64		57.7		1.42 ± 1.98
FIGO Stage			0.085		0.026		0.169		0.893
I-II	20	60		2.20 ± 3.25		35		1.15 ± 2.27
III-IV	37	81.5		4.38 ± 3.50		54.1		1.08 ± 1.55
Residual disease			0.611		0.135		0.716		0.970
None/Optimal	31	71		2.97 ± 3.33		45.2		1.1 ± 1.98
Sub-optimal	26	76.9		4.38 ± 3.71		50		1.12 ± 1.63
Histologic type			0.847		0.320		0.462		0.271
Serous	24	75		4.17 ± 3.66		41.7		0.79 ± 1.35
No Serous	33	72.7		3.21 ± 3.46		51.5		1.33 ± 2.08
Histologic Grade			0.061		0.063		0.629		0.636
I-II	34	64.7		1.65 ± 0.48		50		1.50 ± 0.50
III	23	87		1.87 ± 0.34		43.5		1.43 ± 0.50
Ascites
<100 ml	23	65.2	0.230	3.35 ± 3.74	0.646	39.1	0.306	0.83 ± 1.58	0.345
>100 ml	34	79.2		3.79 ± 3.45		52.9		1.29 ± 1.96
Cytology					0.452		0.503		0.892
negative	28	71.4	0.700	3.25 ± 3.58		42.9		1.07 ± 1.96
positive	29	75.9		3.97 ± 3.54		51.7		1.14 ± 1.70

p¹: Chi-Square test; p²: Student test; %: Positivity percentage; SD: standard deviation.